Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Terminated2
Other1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT01903473Phase 2Terminated
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Acute Graft-Versus-Host DiseaseChronic Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
PrincipalinvestigatorStart date: 2013-07-01
NCT01045382Phase 2Terminated
MSC and HSC Coinfusion in Mismatched Minitransplants
Hodgkin's DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Lymphocytic, Chronic+6 more
StudychairStart date: 2010-07-01
NCT00603330Phase 2Unknown
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
Graft-versus-host DiseaseLow Donor T-cell ChimerismPoor Graft Function
StudychairStart date: 2008-01-01

Research Network

Collaboration Network

30 collaborators·72 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yves Beguin, MD, PhD

CHU-ULg

Very Similar
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+9 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+12 more
Collaborated on 2 trials
Similarity Score128%

Lucien Noens, MD, PhD

UZG Gent

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Wilfried Schroyens, MD, PhD

UZA Antwerpen

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Chantal Doyen, MD, PhD

Cliiques Universitaire Mont-Godinne, Yvoir

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Chantal Lechanteur, PhD

CHU-ULg

Very Similar
2 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Evelyne Willems, MD

CHU-ULg

Very Similar
2 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Pierre Zachée, MD, PhD

ZNA Antwerpen

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Etienne Baudoux, MD

CHU-ULg

Very Similar
2 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Rik Schots, MD, PhD

AZ VUB, Brussels

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Dominik Selleslag, MD, PhD

AZ Brugge

Very Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+6 more

Worked with same sponsors:

AZ Sint-Jan AVCliniques universitaires Saint-Luc- Université Catholique de Louvain+6 more
Collaborated on 1 trial
Similarity Score94%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01903473Phase 2PrincipalInvestigator

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Acute Graft-Versus-Host DiseaseChronic Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
Terminated
NCT01045382Phase 2StudyChair

MSC and HSC Coinfusion in Mismatched Minitransplants

Hodgkin's DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Lymphocytic, Chronic+6 more
Terminated
NCT00603330Phase 2StudyChair

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Graft-versus-host DiseaseLow Donor T-cell ChimerismPoor Graft Function
Unknown

All 3 trials loaded